1. Home
  2. BHVN vs WINA Comparison

BHVN vs WINA Comparison

Compare BHVN & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • WINA
  • Stock Information
  • Founded
  • BHVN 2013
  • WINA 1988
  • Country
  • BHVN United States
  • WINA United States
  • Employees
  • BHVN N/A
  • WINA N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • WINA Other Specialty Stores
  • Sector
  • BHVN Health Care
  • WINA Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • WINA Nasdaq
  • Market Cap
  • BHVN 1.7B
  • WINA 1.4B
  • IPO Year
  • BHVN 2017
  • WINA 1993
  • Fundamental
  • Price
  • BHVN $15.63
  • WINA $487.57
  • Analyst Decision
  • BHVN Strong Buy
  • WINA
  • Analyst Count
  • BHVN 14
  • WINA 0
  • Target Price
  • BHVN $49.23
  • WINA N/A
  • AVG Volume (30 Days)
  • BHVN 2.4M
  • WINA 78.9K
  • Earning Date
  • BHVN 11-11-2025
  • WINA 10-16-2025
  • Dividend Yield
  • BHVN N/A
  • WINA 2.32%
  • EPS Growth
  • BHVN N/A
  • WINA 2.48
  • EPS
  • BHVN N/A
  • WINA 11.23
  • Revenue
  • BHVN N/A
  • WINA $83,395,300.00
  • Revenue This Year
  • BHVN N/A
  • WINA $6.56
  • Revenue Next Year
  • BHVN $2,195.07
  • WINA $3.61
  • P/E Ratio
  • BHVN N/A
  • WINA $43.57
  • Revenue Growth
  • BHVN N/A
  • WINA 0.98
  • 52 Week Low
  • BHVN $12.79
  • WINA $295.79
  • 52 Week High
  • BHVN $55.70
  • WINA $527.37
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 51.87
  • WINA 55.40
  • Support Level
  • BHVN $14.32
  • WINA $494.71
  • Resistance Level
  • BHVN $16.24
  • WINA $526.81
  • Average True Range (ATR)
  • BHVN 0.82
  • WINA 11.78
  • MACD
  • BHVN 0.11
  • WINA -4.08
  • Stochastic Oscillator
  • BHVN 60.92
  • WINA 33.59

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About WINA Winmark Corporation

Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.

Share on Social Networks: